PL374999A1 - Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives - Google Patents
Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivativesInfo
- Publication number
- PL374999A1 PL374999A1 PL03374999A PL37499903A PL374999A1 PL 374999 A1 PL374999 A1 PL 374999A1 PL 03374999 A PL03374999 A PL 03374999A PL 37499903 A PL37499903 A PL 37499903A PL 374999 A1 PL374999 A1 PL 374999A1
- Authority
- PL
- Poland
- Prior art keywords
- sub
- oxazol
- preparing
- benzoic acid
- acid derivatives
- Prior art date
Links
- IMAITKPPSLYKDS-UHFFFAOYSA-N 3-(1,3-oxazol-2-yl)benzoic acid Chemical class OC(=O)C1=CC=CC(C=2OC=CN=2)=C1 IMAITKPPSLYKDS-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical group [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 150000002916 oxazoles Chemical class 0.000 abstract 1
- 235000005074 zinc chloride Nutrition 0.000 abstract 1
- 239000011592 zinc chloride Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39028502P | 2002-06-20 | 2002-06-20 | |
| US45047803P | 2003-02-27 | 2003-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL374999A1 true PL374999A1 (en) | 2005-11-14 |
Family
ID=30003150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03374999A PL374999A1 (en) | 2002-06-20 | 2003-06-20 | Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US7115747B2 (enExample) |
| EP (1) | EP1532123B1 (enExample) |
| JP (1) | JP2005533811A (enExample) |
| CN (1) | CN1324017C (enExample) |
| AT (1) | ATE370131T1 (enExample) |
| AU (1) | AU2003249344A1 (enExample) |
| BR (1) | BR0312439A (enExample) |
| CA (1) | CA2489988A1 (enExample) |
| CO (1) | CO5670350A2 (enExample) |
| DE (1) | DE60315664D1 (enExample) |
| EA (1) | EA008389B1 (enExample) |
| IL (1) | IL165763A0 (enExample) |
| MX (1) | MXPA04012630A (enExample) |
| NO (1) | NO20045497L (enExample) |
| NZ (1) | NZ537390A (enExample) |
| PL (1) | PL374999A1 (enExample) |
| WO (1) | WO2004000821A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0316629A (pt) * | 2002-11-27 | 2005-10-11 | Elan Pharm Inc | Uréias e carbamatos substituìdos |
| TW200738701A (en) * | 2005-07-26 | 2007-10-16 | Du Pont | Fungicidal carboxamides |
| US7872009B2 (en) * | 2005-11-21 | 2011-01-18 | Amgen Inc. | Beta-Secretase modulators and methods of use |
| US7838676B2 (en) * | 2005-11-21 | 2010-11-23 | Amgen Inc. | Beta-secretase modulators and methods of use |
| US7745484B2 (en) | 2005-11-21 | 2010-06-29 | Amgen Inc. | Beta-secretase modulators and methods of use |
| EP1971598A1 (en) | 2005-11-21 | 2008-09-24 | Amgen Inc. | Beta-secretase modulators and methods of use |
| WO2008137954A2 (en) * | 2007-05-07 | 2008-11-13 | Environmental Packaging Technologies Limited | Universal shipping container |
| US8163909B2 (en) | 2007-05-25 | 2012-04-24 | Amgen Inc. | Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| JP5440984B2 (ja) * | 2007-05-25 | 2014-03-12 | アムジエン・インコーポレーテツド | β−セクレターゼ修飾剤としての置換ヒドロキシエチルアミン化合物および使用方法 |
| US7803809B2 (en) | 2008-11-12 | 2010-09-28 | Amgen Inc. | Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use |
| KR20110073511A (ko) | 2008-09-11 | 2011-06-29 | 암젠 인크 | 베타세크레타제 조절제로서의 스피로-테트라사이클릭 고리 화합물 및 사용 방법 |
| WO2011063233A1 (en) | 2009-11-23 | 2011-05-26 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| EP2504330A1 (en) | 2009-11-23 | 2012-10-03 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| CA2788363A1 (en) | 2010-01-19 | 2011-07-28 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| JP5584352B2 (ja) | 2010-03-15 | 2014-09-03 | アムジエン・インコーポレーテツド | β−セクレターゼ調節剤としてのアミノ−ジヒドロオキサジン系およびアミノ−ジヒドロチアジン系スピロ化合物ならびにそれらの医学的用途 |
| CA2791281A1 (en) | 2010-03-15 | 2011-09-22 | Amgen Inc. | Spiro-tetracyclic ring compounds as beta-secretase modulators |
| EP2673279A1 (en) | 2011-02-07 | 2013-12-18 | Amgen Inc. | 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use |
| EP2758406A1 (en) | 2011-09-21 | 2014-07-30 | Amgen Inc. | Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| US9725469B2 (en) | 2012-11-15 | 2017-08-08 | Amgen, Inc. | Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| US11272751B2 (en) | 2016-03-01 | 2022-03-15 | Nicholas Popejoy | Protective headgear, impact diffusing systems and methods |
| US9462841B1 (en) | 2016-03-01 | 2016-10-11 | William Popejoy | Protective headgear and shoulder pad apparatus and methods |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20020276A1 (es) * | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
| CA2462851A1 (en) | 2001-10-04 | 2003-04-10 | Elan Pharmaceuticals, Inc. | Hydroxypropylamines |
| AR039555A1 (es) * | 2001-11-08 | 2005-02-23 | Upjohn Co | Derivados n,n'-sustituidos de 1,3-diamino-2-hidroxipropano |
| GB0325830D0 (en) * | 2003-11-05 | 2003-12-10 | Novartis Ag | Organic compounds |
-
2003
- 2003-06-20 CN CNB038144476A patent/CN1324017C/zh not_active Expired - Fee Related
- 2003-06-20 MX MXPA04012630A patent/MXPA04012630A/es active IP Right Grant
- 2003-06-20 NZ NZ537390A patent/NZ537390A/en unknown
- 2003-06-20 PL PL03374999A patent/PL374999A1/xx unknown
- 2003-06-20 CA CA002489988A patent/CA2489988A1/en not_active Abandoned
- 2003-06-20 JP JP2004516055A patent/JP2005533811A/ja active Pending
- 2003-06-20 DE DE60315664T patent/DE60315664D1/de not_active Expired - Lifetime
- 2003-06-20 AU AU2003249344A patent/AU2003249344A1/en not_active Abandoned
- 2003-06-20 EA EA200401510A patent/EA008389B1/ru unknown
- 2003-06-20 AT AT03761206T patent/ATE370131T1/de not_active IP Right Cessation
- 2003-06-20 US US10/600,100 patent/US7115747B2/en not_active Expired - Fee Related
- 2003-06-20 EP EP03761206A patent/EP1532123B1/en not_active Expired - Lifetime
- 2003-06-20 WO PCT/US2003/019585 patent/WO2004000821A1/en not_active Ceased
- 2003-06-20 BR BR0312439-8A patent/BR0312439A/pt not_active IP Right Cessation
-
2004
- 2004-12-14 IL IL16576304A patent/IL165763A0/xx unknown
- 2004-12-16 NO NO20045497A patent/NO20045497L/no not_active Application Discontinuation
-
2005
- 2005-01-20 CO CO05004558A patent/CO5670350A2/es not_active Application Discontinuation
-
2006
- 2006-10-03 US US11/538,155 patent/US20070105921A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60315664D1 (de) | 2007-09-27 |
| CN1324017C (zh) | 2007-07-04 |
| EP1532123A1 (en) | 2005-05-25 |
| NO20045497D0 (no) | 2004-12-16 |
| NO20045497L (no) | 2005-03-07 |
| EA008389B1 (ru) | 2007-04-27 |
| CN1662510A (zh) | 2005-08-31 |
| MXPA04012630A (es) | 2005-09-30 |
| BR0312439A (pt) | 2005-05-10 |
| EP1532123B1 (en) | 2007-08-15 |
| AU2003249344A1 (en) | 2004-01-06 |
| US20070105921A1 (en) | 2007-05-10 |
| NZ537390A (en) | 2006-07-28 |
| JP2005533811A (ja) | 2005-11-10 |
| CO5670350A2 (es) | 2006-08-31 |
| CA2489988A1 (en) | 2003-12-31 |
| HK1081543A1 (zh) | 2006-05-19 |
| IL165763A0 (en) | 2006-01-15 |
| ATE370131T1 (de) | 2007-09-15 |
| US7115747B2 (en) | 2006-10-03 |
| EA200401510A1 (ru) | 2005-06-30 |
| WO2004000821A1 (en) | 2003-12-31 |
| US20040063965A1 (en) | 2004-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL165763A0 (en) | Process for preparing 5-(1,3-oxazol-2-yl)benzoic acid derivatives | |
| MXPA05011150A (es) | 2-hidroxi-3-diaminoalcanos de benzamida. | |
| TW200510405A (en) | Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors | |
| EA200101194A1 (ru) | Производные 4,5,6,7-тетрагидроиндазола в качестве противоопухолевых средств | |
| CA2665931C (en) | Hydrobenzamide derivatives as inhibitors of hsp90 | |
| GB0318447D0 (en) | Therapeutic agents | |
| JO2282B1 (en) | Oxazole derivatives | |
| GB0318343D0 (en) | No title | |
| MXPA05012415A (es) | Inhibidores de glutamina fructosa-3-fosfato amidotransferasa (gfat). | |
| GEP20074045B (en) | (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease | |
| DE60012751D1 (de) | Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz | |
| EA200500006A1 (ru) | Лекарственное средство для лечения нейродегенеративных заболеваний | |
| PL1685142T3 (pl) | Pochodne kwasu fosfinowego, inhibitory beta-sekterazy do leczenia choroby Alzheimera | |
| PT1989174E (pt) | Derivados de ciclo-hexilmetilo substituídos | |
| AU2003242144A1 (en) | Processes for producing epoxytriazole derivative and intermediate therefor | |
| PT1709027E (pt) | Compostos do tipo hidrazida e sua utilização em composições farmacêuticas para o tratamento de doenças cardiovasculares | |
| EP1036793A3 (en) | A process for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative | |
| ATE496907T1 (de) | Verfahren zur herstellung von cilostazol | |
| TW200621685A (en) | Hydroxynaphthoic acid hydrazide compound and method for preparing the same | |
| NO20073213L (no) | Fremgangsmate for fremstilling av tiofenglykosidderivater | |
| NO20033049L (no) | Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1-metylpiperidin | |
| MXPA05009122A (es) | Derivados de acido benzoilureidopiridil-piperidin-y pirrolidin-carboxilico sustituido, metodo para su produccion y su uso. | |
| MXPA05013732A (es) | Proceso para preparacion de sensibilizador de insulina y compuesto intermediario del mismo. | |
| WO2004067505A3 (en) | Bismuth dithiocarbamate compounds and uses thereof | |
| TW200612912A (en) | Benzyloxy derivatives as maob inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |